Enteric vaccines for pediatric use. Workshop summary.
Diarrheal diseases remain a major cause of death in children under 5 in less developed countries (LDCs). Vaccine development and implementation offers the best near-term approach to alleviating this problem. For this reason, a workshop to examine the possibilities for making enteric vaccines available to meet the specific needs of children in LDCs was convened in Virginia on April 24-26, 2004. Discussants considered research and development needs, regulatory and business issues, and previous experiences with enteric vaccine development and implementation. No insurmountable roadblocks to progress in this area were noted, and the possibility currently exists that properly supported efforts will enable the realization of enteric vaccines for pediatric use.
Walker
Richard I
RI
Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike (HFM-425), Rockville, MD 20851-1448, USA. walkerri@cber.fda.gov
Van De Verg
Lillian L
LL
Hall
Robert H
RH
Schmitt
Clare K
CK
Woo
Katherine
K
Hale
Victoria
V
D001428:Bacterial Vaccines / Q000191:economics / Q000276:immunology*; D002675:Child, Preschool; D003906:Developing Countries; D003967:Diarrhea / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control; D004755:Enterobacteriaceae / Q000276:immunology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D032541:Mass Vaccination
D001428:Bacterial Vaccines